The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[4-(Naphthalen-2-yloxymethyl)-benzoylamino]-benzoic acid ID: ALA130615
Chembl Id: CHEMBL130615
PubChem CID: 10620813
Max Phase: Preclinical
Molecular Formula: C25H19NO4
Molecular Weight: 397.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccccc1C(=O)O)c1ccc(COc2ccc3ccccc3c2)cc1
Standard InChI: InChI=1S/C25H19NO4/c27-24(26-23-8-4-3-7-22(23)25(28)29)19-11-9-17(10-12-19)16-30-21-14-13-18-5-1-2-6-20(18)15-21/h1-15H,16H2,(H,26,27)(H,28,29)
Standard InChI Key: QQYJPVLTXFQSIE-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.43Molecular Weight (Monoisotopic): 397.1314AlogP: 5.37#Rotatable Bonds: 6Polar Surface Area: 75.63Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.55CX Basic pKa: ┄CX LogP: 5.93CX LogD: 2.57Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: -0.82
References 1. Hasegawa M, Takenouchi K, Takahashi K, Takeuchi T, Komoriya K, Uejima Y, Kamimura T.. (1997) Novel naphthalene derivatives as inhibitors of human immunoglobulin E antibody production., 40 (4): [PMID:9046329 ] [10.1021/jm9605041 ]